Compositions and methods for modulation of SMN2 splicing in a subject

Details for Australian Patent Application No. 2010262862 (hide)

Owner Genzyme Corporation Cold Spring Harbor Laboratory Isis Pharmaceuticals, Inc.

Inventors Bennett, C. Frank; Hung, Gene; Rigo, Frank; Krainer, Adrian R.; Hua, Yimin; Passini, Marco A.; Shihabuddin, Lamya; Cheng, Seng H.; Klinger, Katherine W.

Agent Pizzeys

Pub. Number AU-A-2010262862

PCT Pub. Number WO2010/148249

Priority 61/218,031 17.06.09 US

Filing date 17 June 2010

Wipo publication date 23 December 2010

International Classifications

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

Event Publications

19 January 2012 PCT application entered the National Phase

  PCT publication WO2010/148249 Priority application(s): WO2010/148249

2 February 2012 Assignment before Grant

  Cold Spring Harbor Laboratory; Genzyme Corporation; Isis Pharmaceuticals, Inc. The application has been assigned to Cold Spring Harbor Laboratory; Isis Pharmaceuticals, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010262868-Marking device for a personal mobility vehicle

2010262859-Medical device for modification of left atrial appendage and related systems and methods